<DOC>
	<DOCNO>NCT01079624</DOCNO>
	<brief_summary>Academic phase 1 study investigates effect two incretin hormone glucose-insulinotropic peptide ( GIP ) glucagon-like peptide-1 ( GLP-1 ) gastric empty , appetite , insulin release glucose disposal body . The hypothesis incretin hormone stimulate insulin release also inhibit gastric empty . This effect utilized drug development .</brief_summary>
	<brief_title>GIP GLP-1 Gastric Emptying , Appetite Insulin-glucose</brief_title>
	<detailed_description>Effects GIP GLP-1 gastric emptying , appetite control insulin release relation glucose level bloodstream . Infusions GIP GLP-1 give simultaneous gastric empty study appetite questionnaire blood sample analysis insulin , glucose , gut hormone glucagon , ghrelin , PYY , well administer , GIP GLP-1 .</detailed_description>
	<mesh_term>Glucagon</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<criteria>Men woman 1850 year old ; otherwise healthy HIV HCB , HCV negative Age &gt; 50 , type disease drug user .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Incretin hormone</keyword>
	<keyword>Glucose-insulinotropic peptide</keyword>
	<keyword>Glucagon-like peptide-1</keyword>
	<keyword>Gastric empty</keyword>
	<keyword>Appetite</keyword>
	<keyword>Glucose disposal</keyword>
	<keyword>Gut hormone</keyword>
</DOC>